1. Home
  2. RDIB vs SWKH Comparison

RDIB vs SWKH Comparison

Compare RDIB & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RDIB

Reading International Inc Class B

N/A

Current Price

$12.04

Market Cap

256.7M

ML Signal

N/A

Logo SWK Holdings Corporation

SWKH

SWK Holdings Corporation

N/A

Current Price

$17.40

Market Cap

205.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
RDIB
SWKH
Founded
1937
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Diversified Financial Services
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
256.7M
205.9M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
RDIB
SWKH
Price
$12.04
$17.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
4.6K
8.5K
Earning Date
04-01-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
120.89
EPS
N/A
1.85
Revenue
$211,292,000.00
$40,149,000.00
Revenue This Year
N/A
$52.93
Revenue Next Year
$13.42
N/A
P/E Ratio
N/A
$9.36
Revenue Growth
7.11
62.38
52 Week Low
$5.81
$13.17
52 Week High
$14.95
$20.49

Technical Indicators

Market Signals
Indicator
RDIB
SWKH
Relative Strength Index (RSI) 57.04 52.90
Support Level $10.73 $17.22
Resistance Level $11.55 $17.41
Average True Range (ATR) 0.41 0.19
MACD 0.02 -0.02
Stochastic Oscillator 63.29 56.60

Price Performance

Historical Comparison
RDIB
SWKH

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

Share on Social Networks: